This 9%-yielding FTSE 250 dividend superstar looks like a hidden gem to me

FTSE 250 investment firm abrdn has fallen 32% in a year and was demoted from the FTSE 100. But now it looks very undervalued and pays a 9% yield.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

Long-term vs short-term investing concept on a staircase

Image source: Getty Images

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

FTSE 250 global investment firm abrdn (LSE: ABDN) has had a terrible 12 months.

It was demoted from the FTSE 100 at the end of August 2023. This happened because the shares had fallen 15% in the year to that point, reducing its market capitalisation by 25%.

The relegation automatically triggered a wave of fresh selling from funds unable to hold non-FTSE 100 stocks.

And in a 24 January trading update, it said it is cutting 500 jobs to help reduce costs by £150m.

However, although I rarely buy stocks outside the FTSE 100 either, several things appeal to me about abrdn right now.

Serious ex-appeal

One of them is that this is not the first time abrdn has been relegated from the FTSE 100 to the FTSE 250. It happened a year before as well.

In the run-up to its previous demotion, its shares tumbled. They then crashed when the relegation announcement was made official in August 2022.

The company then cut some costs as it is doing now and added different revenue streams.

It was then promoted back to the FTSE 100 just four months later, and its shares spiked back up again.

Why might it be promoted again?

The current round of cost-cutting is deep and looks long overdue. According to the company, it will remove layers of management — always a good thing in my view.

It will also outsource more technology, which should not just reduce costs but increase operational efficiency, I think.

With overheads reduced, the company should be able to pump more money into its latest revenue generators.

Its 2022 acquisition of interactive investor was the key driver for abrdn’s 4% rise in operating revenue in H1 2023, for example.

The purchase of Tekla Capital Management’s healthcare funds also looks promising. US healthcare expenditure per capita has grown at a compound annual rate of 6% since the 1980s.

Consensus analyst expectations are now for abrdn’s earnings to rise by 89% a year until the end of 2026.

One risk in the stock is that this business reorganisation might fail. Another is that it might not be able to attract new net inflows into its funds.

Doubly undervalued against its peers

The automatic devaluation of abrdn after the FTSE 100 demotion, has left its shares undervalued on two key measures.

On a price-to-book ratio (P/B) basis, it trades at just 0.5 – the lowest in its peer group, the average P/B of which is 2.9.

The peer group comprises Caledonia Investments (at 0.6), Bridgepoint Group (2.7), St. James’s Place (2.8), and Hargreaves Lansdown (5.3).

On a price-to-sales ratio (P/S) basis, abrdn trades at 1.9 against a peer group average of 5.8. St. James’s Place is at 0.3, Hargreaves Lansdown at 5.1, Bridgepoint Group at 6.7, and Caledonia Investments at 10.9.

Therefore, on both measurements, abrdn is very undervalued relative to its peers.

I already hold several stocks in the financial sector, so buying more would unbalance my portfolio.

If I did not, I would probably buy abrdn now both for its growth potential and for its undervalued shares.

At least as appealing as these is its big yield – currently just over 9%. This is one of the very highest in either the FTSE 250 or FTSE 100.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Simon Watkins has no position in any of the shares mentioned. The Motley Fool UK has recommended Hargreaves Lansdown Plc. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Great dividend stocks! Here’s the forecast for Associated British Food shares to 2027

Associated British Foods' shares have dropped in value this year. Does this present a dip-buying opportunity for dividend investors to…

Read more »

Investing Articles

Should I sell my FTSE All-Share index fund and buy a S&P 500 tracker instead?

Harvey Jones is wondering whether now is a good time to invest more money in the S&P 500, after a…

Read more »

Investing Articles

Should I buy dirt-cheap BT shares after the recent pullback?

BT shares were on the up but now they're sliding again after the board trimmed full-year guidance. Now Harvey Jones…

Read more »

Investing Articles

Up 28%, can the easyJet share price keep rising?

The easyJet share price has gained altitude over one year but plunged over five. Is now an attractive time for…

Read more »

British Isles on nautical map
Investing Articles

Should I buy more BAE Systems shares at 1,350p?

BAE Systems shares have had a fantastic run since early 2022, yet still don't appear overvalued. Is it now time…

Read more »

Young woman working at modern office. Technical price graph and indicator, red and green candlestick chart and stock trading computer screen background.
Investing Articles

7% yield and a cheap valuation! Is this one of the best shares to buy this month?

Christopher Ruane has been looking for cheap shares to buy. This one has a 7% dividend yield, so is it…

Read more »

Man writing 'now' having crossed out 'later', 'tomorrow' and 'next week'
Investing Articles

Should I buy National Grid shares for the big dividend before it’s too late?

This year's price weakness has left National Grid shares on what looks like a tempting valuation. I hope it doesn't…

Read more »

Investing Articles

There are now 5,000 ISA millionaires! See the surprising UK dividend shares they’re buying

The number of ISA millionaires is growing all the time and guess what? They're really into blue-chip dividend shares listed…

Read more »